Nephrology News

• EASD 2022 Is Continuous Glucose Monitoring for Everyone With Diabetes? At the EASD annual meeting, two experts debated '...and CGM for all," with nuanced takes regarding people with type 2 diabetes not on insulin.
  Medscape Medical News, October 05, 2022
• New Consensus on Diabetes and Chronic Kidney Disease Together ADA and KDIGO, an international kidney disease group, together summarize their current guidance on how to manage patients with diabetes and chronic kidney disease.
  Medscape Medical News, October 05, 2022
• Comparing Prevention and Neurostimulation for Dementia Noninvasive neurostimulation is a promising technique that could one day provide treatment for dementia. For now, clinicians continue to stress the importance of preventive measures.
  Medscape Medical News, October 04, 2022
• Newer Drugs Not Cost-Effective for First-Line Diabetes Therapy Costs of SGLT2 inhibitors and GLP-1 receptor agonists 'need to be lowered substantially' to improve health outcomes and prevent health disparities in patients with type 2 diabetes, say researchers.
  Medscape Medical News, October 04, 2022
• HFSA 2022 Salt Pills for Patients With Acute Decompensated Heart Failure? It may seem counterintuitive, but a new trial testing extra sodium intake in patients receiving high-dose IV diuretics for acute HF challenges routine use of salt restriction in that setting.
  Medscape Medical News, October 03, 2022
• HFSA 2022 Optimized HF Meds May Lessen MR Severity, Avoid Invasive Therapy Patients with heart failure and mitral regurgitation should get at least 6 months of optimized guideline-directed medical therapy before invasive mitral repair is considered, researchers say.
  Medscape Medical News, October 03, 2022
• EASD 2022 Improve Diagnosis of Type of Heart Failure Common in Diabetes Heart failure with preserved ejection fraction is common in people with type 2 diabetes but is often hard to recognize. Treatments newly proven to be effective make diagnosis an imperative.
  Medscape Medical News, September 30, 2022
• Gender-Based Violence Is a Cardiovascular Risk Factor Gender-based violence not only has psychological effects, but can also damage the heart, as a cardiologist reported at a recent conference.
  Medscape Medical News, September 30, 2022
• Sex Differences Seen in Inflammatory Arthritis Healthcare Use Women’s higher risk of conditions such as osteoarthritis and pain and fatigue may help to explain why overall healthcare resource use was higher in female patients with inflammatory arthritis.
  Medscape Medical News, September 30, 2022
• Why Private Practice Will Always Survive Although the majority of physicians are employed, many doctors are leaving employment to start a private practice. Seven physicians talk about why they chose private practice over employment.
  Medscape Medical News, September 29, 2022
• Food Insecurity a Growing Problem for Many With CVD The number of Americans with cardiovascular disease who have limited or uncertain access to food has more than doubled over the last 20 years, a review of NHANES data show.
  Medscape Medical News, September 29, 2022
• Severe COVID-19–Related Outcomes Found Worse in Men With RA A retrospective electronic health record study of patients with rheumatoid arthritis and COVID-19 showed that men had more baseline comorbidities and increased risk of COVID-19 outcomes than females.
  Medscape Medical News, September 29, 2022
• Poll: Do Doctors Come to Work Sick? Whereas physicians coming to work sick was fairly common in the past, has the COVID pandemic changed the culture of coming to work while feeling ill?
  Medscape Reader Polls, September 28, 2022
• Female Docs Rarely Earn Highest Drug, Device Payouts: Study A new study finds gender disparities common in industry payouts, resulting in female physicians earning less and having fewer opportunities to network and advance their careers.
  Medscape Medical News, September 28, 2022
• EASD 2022 Will Insulin Treatment Disappear in Type 2 Diabetes? At EASD, two experts debate the future of insulin therapy for type 2 diabetes.
  Medscape Medical News, September 28, 2022
• Coffee Linked to Reduced Cardiovascular Disease and Mortality Mild to moderate intake of ground, instant, and decaffeinated coffee is associated with lower mortality and cardiovascular disease risk, and can be considered part of a healthy diet, researchers say.
  Medscape Medical News, September 27, 2022
• Post-Transplant Diabetes Can Be Predicted in Kidney Recipients Combined family history and early postoperative plasma glucose, but not glycated albumin, predicted post-transplant diabetes mellitus in kidney recipients in a new study.
  First Look, September 27, 2022
• New Update Focuses on Acute Kidney Injury Management in Cirrhosis Prevent volume loss, manage risk factors, hold beta blockers, and stop NSAIDs are among the key recommendations in a new update to prevent acute kidney injury in patients with cirrhosis.
  Medscape Medical News, September 27, 2022
• Renowned Oncologist Nicholas Vogelzang, MD, Dies at 72 Vogelzang left his mark as a medical oncologist and cancer investigator, helping shepherd a handful of cancer drugs through clinical trials.
  Medscape Medical News, September 27, 2022
• Uncontrolled BP Linked to One Third of ED Visits for CVD In a sample of more than 20 million emergency department visits, about one third of CVD-related visits were related to poorly controlled hypertension.
  Medscape Medical News, September 26, 2022